Pet Pharm Biotech Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 5, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	3,206	1,656	-	-
Enterprise Value	2,808	1,535	-	-
Last Close Price	62.60	39.48	-	-
PE Ratio	152.73	114.14	-	-
PS Ratio	20.16	12.67	-	-
PB Ratio	3.58	2.84	-	-
P/TBV Ratio	3.61	2.89	-	-
P/OCF Ratio	90.43	57.32	-	-
EV/Sales Ratio	17.66	11.75	-	-
EV/EBITDA Ratio	71.66	55.39	-	-
EV/EBIT Ratio	290.34	189.22	-	-
Debt / Equity Ratio	0.19	0.08	0.12	0.32
Debt / EBITDA Ratio	4.44	1.58	1.98	4.49
Net Debt / Equity Ratio	-0.44	-0.24	-0.29	0.19
Net Debt / EBITDA Ratio	-12.53	-4.97	-4.94	2.72
Net Debt / FCF Ratio	3.47	0.87	5.46	-0.92
Asset Turnover	-	0.21	0.35	-
Inventory Turnover	-	4.96	6.42	-
Quick Ratio	4.28	1.54	6.18	1.94
Current Ratio	4.40	3.16	10.97	5.05
Return on Equity (ROE)	-	2.91%	3.34%	-
Return on Assets (ROA)	-	0.81%	1.40%	-
Return on Capital Employed (ROCE)	1.00%	1.30%	1.70%	-2.80%
Earnings Yield	0.60%	0.88%	-	-
FCF Yield	-3.57%	-9.63%	-	-
Dividend Yield	0.14%	0.22%	-	-
Payout Ratio	41.76%	55.42%	-	-
Buyback Yield / Dilution	-92.45%	-36.54%	-23.95%	-
Total Shareholder Return	-92.31%	-36.31%	-23.95%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.